W Lilienblum
Overview
Explore the profile of W Lilienblum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hengstler J, Foth H, Gebel T, Kramer P, Lilienblum W, Schweinfurth H, et al.
Crit Rev Toxicol
. 2011 Mar;
41(4):263-91.
PMID: 21438738
Despite the fact that more than 5000 safety-related studies have been published on bisphenol A (BPA), there seems to be no resolution of the apparently deadlocked controversy as to whether...
2.
Lilienblum W, Dekant W, Foth H, Gebel T, Hengstler J, Kahl R, et al.
Arch Toxicol
. 2008 Mar;
82(4):211-36.
PMID: 18322675
During the last two decades, substantial efforts have been made towards the development and international acceptance of alternative methods to safety studies using laboratory animals. In the EU, challenging timelines...
3.
Hengstler J, Foth H, Kahl R, Kramer P, Lilienblum W, Schulz T, et al.
Toxicology
. 2006 Mar;
220(2-3):232-9.
PMID: 16555380
No abstract available.
4.
Lilienblum W, Platt K, Schirmer G, Oesch F, Bock K
Mol Pharmacol
. 1987 Jul;
32(1):173-7.
PMID: 3110592
Inducibility of rat liver microsomal UDP-glucuronosyltransferase was investigated with regard to the substrate structure using 3-, 6-, 7-, 8-, and 9-hydroxybenzo(a)pyrene, all seven phenols of dibenz(a,h)anthracene, 3-hydroxybenz(a)anthracene, and 3-hydroxyfluoranthene as...
5.
Bock K, Lilienblum W, Fischer G, Schirmer G
Arch Toxicol
. 1987 Jan;
60(1-3):22-9.
PMID: 3304211
The role of conjugating enzymes is best understood by looking at the interaction between phase I (mostly cytochromes P-450) and phase II (conjugation) enzymes of drug metabolism. A balance between...
6.
Bock K, Lilienblum W, Fischer G, Schirmer G
Pharmacol Ther
. 1987 Jan;
33(1):23-7.
PMID: 3114774
No abstract available.
7.
Fischer G, Lilienblum W, Ullrich D, Bock K
Carcinogenesis
. 1986 Sep;
7(9):1405-10.
PMID: 2874897
gamma-Glutamyltranspeptidase (gamma-GT) is known to be increased in putative pre-neoplastic foci but also in the periportal zone I of rat liver under a variety of circumstances not directly related to...
8.
Lilienblum W, IRMSCHER G, Fusenig N, Bock K
Biochem Pharmacol
. 1986 May;
35(9):1517-20.
PMID: 3085679
Methods have been developed which allow quantitative determination of UDP-glucuronyltransferase (UDPGT) and arylhydrocarbon hydroxylase (AHH) activities in unfractionated mouse skin. These methods were used for comparative studies of basal and...
9.
Bock K, Fischer G, Lilienblum W, Schirmer G
Adv Exp Med Biol
. 1986 Jan;
197:171-84.
PMID: 3094334
No abstract available.
10.
Lilienblum W, Bock K
Mol Pharmacol
. 1985 Apr;
27(4):451-8.
PMID: 3982390
Cytotoxic effects of quinones are thought to be mediated by redox cycles between quinones and quinols whereby reactive oxygen species are generated. The role of glucuronidation in preventing these toxic...